Mark A. Rettenmaier

Survival rate comparisons amongst cervical cancer patients treated with an open, robotic-assisted or laparoscopic radical hysterectomy: A five year experience

Alberto A. Mendivil, Mark A. Rettenmaier, Lisa N. Abaid et al. · Surgical Oncology · 2015 · 121 citations

Medicine, Gynecology, Surgery +17

A phase II study of outpatient first-line paclitaxel, carboplatin, and bevacizumab for advanced-stage epithelial ovarian, peritoneal, and fallopian tube cancer

John P. Micha, Bram H. Goldstein, Mark A. Rettenmaier et al. · International Journal of Gynecological Cancer · 2007 · 106 citations

Medicine, Gynecology, Oncology +17

Abraxane in the treatment of ovarian cancer: The absence of hypersensitivity reactions

John P. Micha, Bram H. Goldstein, Connie L. Birk et al. · Gynecologic Oncology · 2005 · 87 citations

Medicine, Oncology, Pharmacology +13

Pilot study assessing robotic laparoscopic hysterectomy and patient outcomes

Randy P. Fiorentino, M.A. Alvarado Zepeda, Bram H. Goldstein et al. · Journal of Minimally Invasive Gynecology · 2006 · 84 citations

Engineering, Gynecology, Surgery +13

Weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease

HD Homesley, JA Blessing, Mark A. Rettenmaier et al. · International Journal of Gynecology & Obstetrics · 1989 · 65 citations

Medicine, Immunology, Obstetrics +6